Serum HE4 as a prognostic marker in endometrial cancer--a population based study (Q43744083)

26 November 2017

Serum HE4 as a prognostic marker in endometrial cancer--a population based study (English)

1 reference

26 November 2017

8

1 reference

26 November 2017

Jermaine Coward

4

0 references

Michael A. Quinn

Michael A Quinn

7

0 references

Penelope M. Webb

Penelope M Webb

12

0 references

Amanda Spurdle

Amanda B Spurdle

13

0 references

Andreas Obermair

Andreas Obermair

14

0 references

author name string

Donal J Brennan

1

1 reference

26 November 2017

Andreas Hackethal

2

1 reference

26 November 2017

Alex M Metcalf

3

1 reference

26 November 2017

Kaltin Ferguson

5

1 reference

26 November 2017

Martin K Oehler

6

1 reference

26 November 2017

Yee Leung

9

1 reference

26 November 2017

Michael Freemantle

10

1 reference

26 November 2017

ANECS Group

11

1 reference

26 November 2017

language of work or name

English

0 references

publication date

6 November 2013

1 reference

26 November 2017

1 reference

26 November 2017

132

1 reference

26 November 2017

159-165

1 reference

26 November 2017

1

1 reference

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Factors predictive of postoperative morbidity and cost in patients with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Follow-up after primary therapy for endometrial cancer: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Efficacy of routine follow-up in patients with recurrent uterine cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Cloning and analysis of mRNAs expressed specifically in the human epididymis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

A Major Human Epididymis-Specific cDNA Encodes a Protein with Sequence Homology to Extracellular Proteinase Inhibitors1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

HE4 in gynecological cancers: report of a European investigators and experts meeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

HE4 is an independent prognostic marker in endometrial cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

PI(3)king apart PTEN's role in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.10.036

10.1016/J.YGYNO.2013.10.036

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference